X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs WOCKHARDT LTD. - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER WOCKHARDT LTD. PFIZER/
WOCKHARDT LTD.
 
P/E (TTM) x 31.7 -15.9 - View Chart
P/BV x 5.0 2.6 193.5% View Chart
Dividend Yield % 0.6 1.3 50.8%  

Financials

 PFIZER   WOCKHARDT LTD.
EQUITY SHARE DATA
    PFIZER
Mar-16
WOCKHARDT LTD.
Mar-17
PFIZER/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs2,7241,129 241.3%   
Low Rs1,611627 256.9%   
Sales per share (Unadj.) Rs440.9363.1 121.4%  
Earnings per share (Unadj.) Rs48.7-20.4 -238.2%  
Cash flow per share (Unadj.) Rs75.8-7.0 -1,086.3%  
Dividends per share (Unadj.) Rs15.0010.00 150.0%  
Dividend yield (eoy) %0.71.1 60.8%  
Book value per share (Unadj.) Rs462.9301.8 153.4%  
Shares outstanding (eoy) m45.75110.55 41.4%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.92.4 203.3%   
Avg P/E ratio x44.5-42.9 -103.7%  
P/CF ratio (eoy) x28.6-125.9 -22.7%  
Price / Book Value ratio x4.72.9 161.0%  
Dividend payout %30.8-48.9 -63.0%   
Avg Mkt Cap Rs m99,16397,063 102.2%   
No. of employees `0002.96.8 42.7%   
Total wages/salary Rs m2,7589,665 28.5%   
Avg. sales/employee Rs Th6,981.75,931.8 117.7%   
Avg. wages/employee Rs Th954.51,428.1 66.8%   
Avg. net profit/employee Rs Th771.1-334.0 -230.9%   
INCOME DATA
Net Sales Rs m20,17040,146 50.2%  
Other income Rs m8571,143 75.0%   
Total revenues Rs m21,02841,289 50.9%   
Gross profit Rs m4,310128 3,367.0%  
Depreciation Rs m1,2391,489 83.2%   
Interest Rs m52,253 0.2%   
Profit before tax Rs m3,923-2,472 -158.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794-211 -850.0%   
Profit after tax Rs m2,228-2,260 -98.6%  
Gross profit margin %21.40.3 6,701.6%  
Effective tax rate %45.78.5 535.5%   
Net profit margin %11.0-5.6 -196.2%  
BALANCE SHEET DATA
Current assets Rs m16,29946,160 35.3%   
Current liabilities Rs m7,59419,258 39.4%   
Net working cap to sales %43.267.0 64.4%  
Current ratio x2.12.4 89.5%  
Inventory Days Days65101 64.8%  
Debtors Days Days2694 27.4%  
Net fixed assets Rs m8,62240,165 21.5%   
Share capital Rs m458553 82.8%   
"Free" reserves Rs m20,72232,814 63.2%   
Net worth Rs m21,18033,367 63.5%   
Long term debt Rs m2531,903 0.1%   
Total assets Rs m29,13789,687 32.5%  
Interest coverage x755.5-0.1 -777,820.6%   
Debt to equity ratio x01.0 0.1%  
Sales to assets ratio x0.70.4 154.6%   
Return on assets %7.70 -89,263.7%  
Return on equity %10.5-6.8 -155.3%  
Return on capital %19.0-0.3 -5,665.7%  
Exports to sales %0.10-   
Imports to sales %17.50-   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,526NA-   
Fx inflow Rs m529,121 0.6%   
Fx outflow Rs m1402,133 6.6%   
Net fx Rs m-886,988 -1.3%   
CASH FLOW
From Operations Rs m3,436-2,695 -127.5%  
From Investments Rs m-6,991-6,863 101.9%  
From Financial Activity Rs m-61912,545 -4.9%  
Net Cashflow Rs m-4,1743,010 -138.6%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 2.3 326.1%  
FIIs % 4.9 7.7 63.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 23.7 15.4 153.9%  
Shareholders   85,207 67,757 125.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Firm US Markets; Sun Pharma, Software Stocks & Other Top Cues to Sway the Markets Today(Pre-Open)

Indian share markets finished the previous trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Blueprint for Sensex 100,000(The 5 Minute Wrapup)

Feb 20, 2018

Investing in stocks is not about index gazing. There are 3-Ms that could help pick the right stocks.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

A New Quest for the Stock Market's MOST Profitable Ideas...(Smart Contrarian)

Feb 23, 2018

If you want to receive the best ideas in the Indian stick markets...you need to heed this important announcement.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 26, 2018 09:15 AM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS